106 related articles for article (PubMed ID: 1559856)
1. AIDS-related treatment receives IND status.
J Am Osteopath Assoc; 1992 Jan; 92(1):46. PubMed ID: 1559856
[No Abstract] [Full Text] [Related]
2. Treatment IND protocol announced for Pneumocystis carinii pneumonia.
Clin Pharm; 1992 Feb; 11(2):99, 103. PubMed ID: 1551304
[No Abstract] [Full Text] [Related]
3. New AIDS drug available.
AORN J; 1992 Feb; 55(2):514. PubMed ID: 1536543
[No Abstract] [Full Text] [Related]
4. Clinical experience with atovaquone on a treatment investigational new drug protocol for Pneumocystis carinii pneumonia.
White A; LaFon S; Rogers M; Andrews E; Brown N
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):280-5. PubMed ID: 7788426
[TBL] [Abstract][Full Text] [Related]
5. FDA authorizes wider use of new oral medication for AIDS.
Oncology (Williston Park); 1991 Dec; 5(12):59. PubMed ID: 1840024
[No Abstract] [Full Text] [Related]
6. Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients.
Dohn MN; Frame PT; Baughman RP; Lafon SW; Smulian AG; Caldwell P; Rogers MD
J Protozool; 1991; 38(6):220S-221S. PubMed ID: 1818178
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone as prophylaxis for Pneumocystis carinii.
Vilar FJ; McKendrick MW; Nash C
Int J STD AIDS; 1996 Jul; 7(4):302. PubMed ID: 8876368
[No Abstract] [Full Text] [Related]
8. Mepron for AIDS-related pneumonia.
Am Pharm; 1993 Mar; NS33(3):14-5. PubMed ID: 8475842
[No Abstract] [Full Text] [Related]
9. Atovaquone: a new oral treatment for pneumocystis.
Nurse Pract; 1993 Sep; 18(9):22. PubMed ID: 8414230
[No Abstract] [Full Text] [Related]
10. Atovaquone to be marketed as oral therapy for Pneumocystis carinii pneumonia.
Clin Pharm; 1993 Mar; 12(3):175-6. PubMed ID: 8491073
[No Abstract] [Full Text] [Related]
11. Atovaquone for Pneumocystis carinii pneumonia.
Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
[No Abstract] [Full Text] [Related]
12. [Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
Pastor C; Lumbreras C; Lizasoain M
Med Clin (Barc); 1994 Oct; 103(12):473-6. PubMed ID: 7996899
[No Abstract] [Full Text] [Related]
13. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS.
Kazanjian P; Armstrong W; Hossler PA; Lee CH; Huang L; Beard CB; Carter J; Crane L; Duchin J; Burman W; Richardson J; Meshnick SR
J Infect Dis; 2001 Mar; 183(5):819-22. PubMed ID: 11181161
[TBL] [Abstract][Full Text] [Related]
14. Rapid high-performance liquid chromatographic assay for atovaquone.
Hansson AG; Mitchell S; Jatlow P; Rainey PM
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):180-2. PubMed ID: 8634763
[TBL] [Abstract][Full Text] [Related]
15. [Therapy and prevention of pneumocystis carinii pneumonia].
Goebel FD; Bogner JR
Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
[No Abstract] [Full Text] [Related]
16. Atovaquone: a new antipneumocystis agent.
Artymowicz RJ; James VE
Clin Pharm; 1993 Aug; 12(8):563-70. PubMed ID: 8222520
[TBL] [Abstract][Full Text] [Related]
17. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Castro M
Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
[TBL] [Abstract][Full Text] [Related]
18. Atovaquone for Pneumocystis carinii pneumonia.
Stoeckle M; Tennenberg A
Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825772
[No Abstract] [Full Text] [Related]
19. Atovaquone for Pneumocystis carinii pneumonia.
Lederman MM; van der Horst C
Ann Intern Med; 1995 Feb; 122(4):314; author reply 314-5. PubMed ID: 7825771
[No Abstract] [Full Text] [Related]
20. Overdose of atovaquone in a patient with AIDS.
Cheung TW
AIDS; 1999 Oct; 13(14):1984-5. PubMed ID: 10513663
[No Abstract] [Full Text] [Related]
[Next] [New Search]